Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashanth K Jayanna

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|October 8, 2008
Liposomes targeted by fusion phage proteinsPrashanth K Jayanna, Vladimir P Torchilin, Valery A Petrenko
Current Protocols in Protein Science|April 23, 2008
Phage display for generating peptide reagentsJennifer R Brigati, Tatiana I Samoylova, Prashanth K Jayanna, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|May 2, 2007
Plasma pharmacokinetics of selamectin after a single topical administration in the American bullfrog (Rana catesbeiana)Jennifer J D'Agostino, Gary West, Dawn M Boothe, et al.
Journal of Clinical and Diagnostic Research : JCDR|September 3, 2013
Chronic lymphoproliferative disorders at an Indian tertiary cancer centre - the panel sufficiency in the diagnosis of chronic lymphocytic leukaemiaGeeta V Patil Okaly, Ashwini R Nargund, Venkataswamy E, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 9, 2010
Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiencyPrashanth K Jayanna, Deepa Bedi, James W Gillespie, et al.
Journal of Clinical and Diagnostic Research : JCDR|June 3, 2017
HER2/<i>neu</i> Testing In 432 Consecutive Breast Cancer Cases using FISH and IHC - A Comparative StudyVenkataswamy Eswarachary, Imran Gorur Mohammed, Prashanth K Jayanna, et al.
Current Drug Delivery|March 22, 2016
A Lipid Base Formulation for Intramuscular Administration of a Novel Sulfur Donor for Cyanide AntagonismKristof Kovacs, Prashanth K Jayanna, Anna Duke, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nanomedicine : Nanotechnology, Biology, and Medicine|October 8, 2008
Liposomes targeted by fusion phage proteinsPrashanth K Jayanna, Vladimir P Torchilin, Valery A Petrenko
Current Protocols in Protein Science|April 23, 2008
Phage display for generating peptide reagentsJennifer R Brigati, Tatiana I Samoylova, Prashanth K Jayanna, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|May 2, 2007
Plasma pharmacokinetics of selamectin after a single topical administration in the American bullfrog (Rana catesbeiana)Jennifer J D'Agostino, Gary West, Dawn M Boothe, et al.
Journal of Clinical and Diagnostic Research : JCDR|September 3, 2013
Chronic lymphoproliferative disorders at an Indian tertiary cancer centre - the panel sufficiency in the diagnosis of chronic lymphocytic leukaemiaGeeta V Patil Okaly, Ashwini R Nargund, Venkataswamy E, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 9, 2010
Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiencyPrashanth K Jayanna, Deepa Bedi, James W Gillespie, et al.
Journal of Clinical and Diagnostic Research : JCDR|June 3, 2017
HER2/<i>neu</i> Testing In 432 Consecutive Breast Cancer Cases using FISH and IHC - A Comparative StudyVenkataswamy Eswarachary, Imran Gorur Mohammed, Prashanth K Jayanna, et al.
Current Drug Delivery|March 22, 2016
A Lipid Base Formulation for Intramuscular Administration of a Novel Sulfur Donor for Cyanide AntagonismKristof Kovacs, Prashanth K Jayanna, Anna Duke, et al.
Pageof 1